Showing 4,981 - 5,000 results of 10,572 for search '"tumors"', query time: 0.12s Refine Results
  1. 4981

    Activating CD137 Signaling Promotes Sprouting Angiogenesis via Increased VEGFA Secretion and the VEGFR2/Akt/eNOS Pathway by Bo Li, Yue Zhang, Runting Yin, Wei Zhong, Rui Chen, Jinchuan Yan

    Published 2020-01-01
    “…Combination of antiangiogenesis and immunotherapy may be an effective strategy for treatment of solid tumors. Our previous work reported that activation of CD137 signaling promotes intraplaque angiogenesis. …”
    Get full text
    Article
  2. 4982

    Case report: Personalized management of treatment resistance in advanced NSCLC patients with mutated epidermal growth factor receptor: special examples and literature review by Jun Wang, Jun Wang, Xiaojing Li, Shuang Dong, Sheng Hu, Fengming Ran, Yu Qian

    Published 2025-02-01
    “…The second mechanism, known as bypass resistance, entails tumor clones utilizing alternative signaling pathways for proliferation. …”
    Get full text
    Article
  3. 4983
  4. 4984

    De-escalation of surgical and radiation treatment in elderly luminal breast cancer patients, single institution report and review of the evidence by Yasmin Korzets, Marian Khatib, Hadar Goldvaser, Yehiel Hibshoosh, Alla Nikolaevski-Berlin, Ido Wolf, Viacheslav Soyfer

    Published 2025-01-01
    “…All patients had clinically node-negative disease with a median tumor size was 13 mm. Five (5%) women had lymphovascular invasion. …”
    Get full text
    Article
  5. 4985

    The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma by Le-Bin Song, Jiao-Chen Luan, Qi-Jie Zhang, Lin Chen, Hao-Yang Wang, Xue-Chen Cao, Ning-Hong Song, Yan Lu

    Published 2021-01-01
    “…Cutaneous melanoma is defined as one of the most aggressive skin tumors in the world. An increasing body of evidence suggested an indispensable association between immune-associated gene (IAG) signature and melanoma. …”
    Get full text
    Article
  6. 4986

    Laparoscopic and Endoscopic cooperative surgery as Rescue-treatment for Advanced gastric Cancer in patients Unfit for Surgery (LE-RACUS): protocol for a feasibility study by Henrik Maltzman, Masami Omae, Fredrik Klevebro, Francisco Baldaque-Silva, Ioannis Rouvelas

    Published 2025-01-01
    “…The inclusion criteria will be patients with gastric cancer cT2-T4aN0M0, Borrman type 1–2 < 5 cm, or type 3 < 2 cm that the tumor board assesses as not fit for gastrectomy. …”
    Get full text
    Article
  7. 4987

    Design of a humanized CD40 agonist antibody with specific properties using AlphaFold2 and development of an anti-PD-L1/CD40 bispecific antibody for cancer immunotherapy by Kun Du, He Huang

    Published 2025-02-01
    “…Furthermore, in humanized transgenic mice challenged with huPD-L1-expressing tumor cells, BA4415 induced superior anti-tumor activity. …”
    Get full text
    Article
  8. 4988

    Antitumor Effect of Demethylzeylasteral (T-96) on Triple-Negative Breast Cancer via LSD1-Mediate Epigenetic Mechanisms by Zhengjie Shen, Yongjuan Gu, Ruiyang Jiang, Heya Qian, Siyuan Li, Lixian Xu, Wenzhe Gu, Yun Zuo

    Published 2022-01-01
    “…Breast cancer ranks first in the incidence of female tumors. Triple-negative breast cancer (TNBC), one type of breast cancer, is more aggressive and has a worse prognosis. …”
    Get full text
    Article
  9. 4989

    Receipt of specialized palliative care and health care utilization at the end of life in hematological cancer patients – the Stockholm experience by Lena von Bahr, Peter Strang, Torbjörn Schultz, Per Fürst

    Published 2025-02-01
    “…Background: The treatments of hematological malignancies tend to be intense, and compared with solid tumors, less is known about the health care consumption during end of life (EOL). …”
    Get full text
    Article
  10. 4990

    Diagnostic performance of artificial intelligence in detection of renal cell carcinoma: a systematic review and meta-analysis by Mahdi Gouravani, Mohammad Shahrabi Farahani, Mohammad Amin Salehi, Shayan Shojaei, Sina Mirakhori, Hamid Harandi, Soheil Mohammadi, Ramy R. Saleh

    Published 2025-01-01
    “…Abstract Objectives The detection of renal cell carcinoma (RCC) tumors in the earlier stages is of great importance for more effective treatment. …”
    Get full text
    Article
  11. 4991

    Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma by Michela Roberto, Maria Bassanelli, Elsa Iannicelli, Silvana Giacinti, Chiara D’Antonio, Anna Maria Aschelter, Paolo Marchetti

    Published 2015-01-01
    “…Renal cell carcinoma accounts for about 2-3% of all malignant tumors. The prevalence of brain metastases from RCC is less than 20% of cases. …”
    Get full text
    Article
  12. 4992

    Nomogram for prognosis prediction in metastatic pancreatic cancer patients undergoing intra-arterial infusion chemotherapy: incorporating immune-inflammation scores and coagulation... by Yifan Yang, Shaoqi Zong, Yongqiang Hua

    Published 2025-01-01
    “…Abstract Background Pancreatic cancer is one of the most malignant tumors with an inferior prognosis. This study aims to determine the prognostic significance of immune-inflammatory scores and coagulation indices in patients with metastatic pancreatic cancer(MPC) and develop a predictive nomogram. …”
    Get full text
    Article
  13. 4993
  14. 4994

    High-Fat Mouse Model to Explore the Relationship between Abnormal Lipid Metabolism and Enolase in Pancreatic Cancer by Lin Qin, Kai Sun, Li Shi, Yushan Xu, Rongping Zhang

    Published 2023-01-01
    “…Hyperlipidemia can promote tumor growth and increase the expression levels of ENO1, ENO2, and ENO3 in subcutaneous tumor formation of pancreatic cancer in mice. …”
    Get full text
    Article
  15. 4995

    Digestive cancers: mechanisms, therapeutics and management by Tianzuo Zhan, Johannes Betge, Nadine Schulte, Lena Dreikhausen, Michael Hirth, Moying Li, Philip Weidner, Antonia Leipertz, Andreas Teufel, Matthias P. Ebert

    Published 2025-01-01
    “…Over the last decade, genomic and functional studies have provided unprecedented insights into the biology of digestive cancers, identifying genetic drivers of tumor progression and key interaction points of tumor cells with the immune system. …”
    Get full text
    Article
  16. 4996

    Direct-Acting Antivirals in Hepatitis C Treatment for Renal Impairment: Liver Safety Concerns and Effectiveness in Peritoneal Dialysis by Hsuan-Yu Hung, Wei-Liang Hung, Ye Gu, Chung-Yu Chen

    Published 2024-12-01
    “…A case–time–control analysis suggested liver instability despite treatment, with comorbid liver tumors (aOR 18.89; 95% CI 5.4–66.12) and hypertension (aOR 4.25; 95% CI 1.49–12.15) linked to higher DILI risk. …”
    Get full text
    Article
  17. 4997

    Expression and prognosis of cellular senescence genes in head and neck squamous cell carcinoma by Chen Feng, Lijuan Zhu, Wei Mao, Pin Dong, Xinwei Chen

    Published 2025-01-01
    “…Abstract Background Cellular senescence refers to cells entering a relatively stable state of cell cycle arrest, which is a barrier that tumor cells must cross to achieve immortalization and plays an extremely important role in preventing the occurrence and development of tumors. …”
    Get full text
    Article
  18. 4998
  19. 4999

    IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status by Thomas S. Worst, Verena Reiner, Ute Gabriel, Christel Weiß, Philipp Erben, Thomas Martini, Christian Bolenz

    Published 2014-01-01
    “…Expression scores were correlated with pathologic characteristics (tumor stage and grade) and with smoking status. Results. …”
    Get full text
    Article
  20. 5000

    Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp-70-Derived 14-mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors by Ilona Hromadnikova, Petra Pirkova, Lucie Sedlackova

    Published 2013-01-01
    “…NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. …”
    Get full text
    Article